Aspira Women's Health Inc. - Common Stock, $0.001 par value (AWHL)
CUSIP: 04537Y208
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, $0.001 par value
- Shares outstanding
- 42,091,923
- Total 13F shares
- 800
- Share change
- -109,774
- Total reported value
- $392
- Price per share
- $0.49
- Number of holders
- 1
- Value change
- -$38,970
- Number of sells
- 2
Quarterly Holders Quick Answers
What is CUSIP 04537Y208?
CUSIP 04537Y208 identifies AWHL - Aspira Women's Health Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 04537Y208:
Top shareholders of AWHL - Aspira Women's Health Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Robert H. Drysdale |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,310,531
|
$4,416,489 | — | 28 Nov 2023 | |
| Jack W. Schuler |
3/4/5
13D/G
|
10%+ Owner · SCHULER JACK W |
9.1%
from 13D/G
|
4,670,234
mixed-class rows
|
$2,050,820 | +$500,000 | 17 Sep 2025 | |
| James T. LaFrance |
3/4/5
|
Director |
—
mixed-class rows
|
606,434
mixed-class rows
|
$2,024,931 | — | 31 Mar 2022 | |
| Robert D. Auerbach |
3/4/5
|
Director |
—
mixed-class rows
|
375,462
mixed-class rows
|
$1,228,683 | — | 09 Feb 2023 | |
| Ruby Sharma |
3/4/5
|
Director |
—
mixed-class rows
|
358,961
mixed-class rows
|
$1,176,328 | — | 09 Feb 2023 | |
| Valerie Barber Palmieri |
3/4/5
|
Executive Chair, Director |
—
class O/S missing
|
267,088
|
$900,087 | — | 16 May 2022 | |
| Nicole Sandford |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
201,740
mixed-class rows
|
$518,977 | — | 28 Oct 2024 | |
| Robert Harry Beechey |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
150,000
|
$480,000 | — | 31 Mar 2022 | |
| Torsten Hombeck |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
55,000
mixed-class rows
|
$181,610 | — | 13 May 2024 | |
| Veronica Gh Jordan |
3/4/5
|
Director |
—
class O/S missing
|
41,620
|
$140,259 | — | 25 Jul 2023 | |
| Minh Hoang Merchant |
3/4/5
|
General Counsel and Secretary |
—
mixed-class rows
|
37,865
mixed-class rows
|
$125,735 | — | 14 Feb 2024 | |
| Sandra Milligan |
3/4/5
|
Interim CEO |
—
mixed-class rows
|
38,644
mixed-class rows
|
$105,551 | — | 31 Dec 2024 | |
| John A. Kallassy |
3/4/5
|
Interim CFO |
—
mixed-class rows
|
50,000
mixed-class rows
|
$80,000 | — | 12 Nov 2024 | |
| Marlene McLennan |
3/4/5
|
Interim Chief Financial Office |
—
class O/S missing
|
25,000
|
$80,000 | — | 01 Dec 2022 | |
| Celeste Rachelle Fralick |
3/4/5
|
Director |
—
mixed-class rows
|
60,665
mixed-class rows
|
$42,466 | — | 31 Mar 2025 | |
| ARMISTICE CAPITAL, LLC |
13D/G
|
— |
5%
|
800,797
|
$24,024 | $0 | 31 Dec 2024 | |
| Ryan Thinh Phan |
3/4/5
|
CSO & COO |
—
class O/S missing
|
3,939
|
$13,274 | — | 24 Jul 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.16%
|
67,484
|
$9,452 | — | 30 Jun 2025 | |
| Jannie Prestridge Herchuk |
3/4/5
|
Director |
—
mixed-class rows
|
87,404
mixed-class rows
|
$8,381 | — | 04 Jun 2025 | |
| John Phillip Ragard |
3/4/5
|
Director |
0.32%
|
134,734
mixed-class rows
|
$7,433 | — | 04 Jun 2025 | |
| Stefanie L. Cavanaugh |
3/4/5
|
Director |
—
mixed-class rows
|
81,994
mixed-class rows
|
$6,517 | — | 04 Jun 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.1%
|
43,090
|
$6,295 | — | 30 Jun 2025 | |
| Ellen O'Connor Vos |
3/4/5
|
Director |
—
mixed-class rows
|
77,257
mixed-class rows
|
$5,937 | — | 04 Jun 2025 | |
| Brian Hungerford |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
100,000
|
— | — | 02 Sep 2025 | |
| Michael William Buhle |
3/4/5
|
Chief Executive Officer |
—
class O/S missing
|
100,000
|
— | — | 22 May 2025 |
Institutional Holders of Aspira Women's Health Inc. - Common Stock, $0.001 par value (AWHL) as of Q3 2025
As of 30 Sep 2025,
Aspira Women's Health Inc. - Common Stock, $0.001 par value (AWHL) was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
800 shares.
The largest 1 holders included
OSAIC HOLDINGS, INC..
This page lists
1
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
2
Q3 2025 holders
1
Holder diff
-1
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.